Products

KidneyIntelX.dkd
Renalytix
Endocrinology & Metabolic AI
KidneyIntelX.

See all 1 product →

About Renalytix

Renalytix is a healthcare AI company focused on transforming kidney disease care through early risk assessment. The company utilizes its KidneyIntelX™ technology to provide data-driven insights to clinical teams. This technology helps clinicians understand a patient’s risk level for progressive decline in kidney function during the earliest stages of diabetic kidney disease.

By identifying patients at low, moderate, or high risk for progressive decline in kidney function over the next five years, KidneyIntelX™ enables clinicians to appropriately target resources and guideline-recommended treatments. This approach aims to improve kidney and overall renal-cardio-metabolic outcomes, shifting the focus from kidney disease to kidney health. The KidneyIntelX.

Focus Areas

artificial intelligence in vitro diagnostics kidney disease diabetic kidney disease prognostic testing risk assessment clinical management biomarker analysis

Business Intelligence

TechnologyAI-enabled in vitro diagnostics platform, cloud-native, machine learning algorithms, integration with electronic health records (EHR)

What Physicians Need to Know

Kidney Disease Care Transformation
Transforming kidney disease care with one simple blood test, enabling clinical teams to understand patient risk for progressive kidney function decline in the earliest stages of diabetic kidney disease.
KidneyIntelX™ Technology
Utilizes KidneyIntelX™ technology and data-driven insights to provide a simple-to-understand risk result, predicting which adult patients with type 2 diabetes and CKD stages 1-3b are at low, moderate, or high risk for progressive kidney function decline over the next 5 years.
Bioprognostic™ Methodology
Employs a highly-reliable, bioprognostic™ methodology to yield risk predictions, allowing clinicians to appropriately target resources and medications for slowing or preempting disease progression.
Early Detection and Intervention
Enables clinicians to focus resources and guideline-recommended treatment accordingly, providing the best chance for improving kidney and overall renal-cardio-metabolic outcomes by identifying high-risk patients early.
FDA Authorization and Medicare Coverage
KidneyIntelX.dkd™ received FDA marketing authorization in 2Q 2023 and final Medicare coverage determination in June 2024.
Physician Tip

Combine information gathered through kidneyintelX.dkd and clinical examination to identify patients at higher to lower risk for CKD progression. This allows for appropriate targeting of resources and medications shown to be more effective at slowing or preempting disease progression in the early stages of CKD.

The KidneyIntelX testing technology is featured in prominent publications, indicating potential for integration with existing clinical workflows and research.

Products by Renalytix

1 product in the directory

KidneyIntelX.dkd
Renalytix
Endocrinology & Metabolic AI
KidneyIntelX.

Videos

News, demos, and interviews about Renalytix.

Loading videos...

Videos load interactively. If none appear, search YouTube for Renalytix →

View all on YouTube

No press coverage or publications on file yet. Know of some? Suggest an edit →

Frequently Asked Questions

KidneyIntelX.dkd is a bioprognostic test that predicts the risk of progressive decline in kidney function over 5 years for adult patients with type 2 diabetes and chronic kidney disease stages 1-3b.
KidneyIntelX.dkd is for adult patients who have type 2 diabetes and chronic kidney disease stages 1-3b.
It provides a simple risk result (low, moderate, or high) that helps clinicians target resources and medications to slow or preempt disease progression in early CKD stages.
KidneyIntelX.dkd utilizes a simple blood test to generate its risk assessment.
Renalytix Clinical Laboratories are located in New York City, NY.

Related Companies

CompuGroup Medical is a leading software and e-health provider for doctors, hospitals, community health centers, laboratories, and more. The company offers a comprehensive suite of solutions that support the entire patient journey, from online scheduling and digital intake to AI-powered electronic health record (EHR) documentation, e-prescribing, lab connectivity, telehealth, remote patient monitoring, and revenue cycle […]

PathologyAILab offers advanced digital cytology services, leveraging a multi-agent AI system for cervical cancer diagnosis. This innovative solution provides comprehensive image analysis to deliver precise and reliable diagnostic insights to healthcare professionals. The service aims to provide rapid results, typically within 2-4 hours, for urgent cases, enabling timely clinical decisions. The process involves submitting digital […]

AiHealth Clinic is a precision metabolic medicine practice and platform based in Bengaluru, India, specializing in diabetes and obesity care. It offers a continuous intelligence approach, moving beyond traditional three-month snapshots of metabolic health. The clinic utilizes continuous glucose monitoring (CGM), GLP-1/GIP therapies, and proprietary AI-driven scoring engines (MMIQ for metabolic health and BMIQ for […]

90Health offers a comprehensive digital solution for managing chronic diseases, aiming to address the significant financial burden these conditions place on the U.S. healthcare system. Their platform integrates AI-powered digital programs with human support to facilitate behavior change and improve patient outcomes. The solution includes access to evidence-based cognitive behavioral lessons designed to help patients […]

AI Tool Finder
AI-powered search. Results may not be comprehensive.